Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

AGM & Interim Management Statement

22 Apr 2009 10:01

RNS Number : 9694Q
Flying Brands Limited
22 April 2009
 



22 April 2009

Flying Brands Limited

AGM & Interim Management Statement 

Flying Brands Limited ("the Group"), the Jersey based home shopping group is pleased to announce that all the tabled resolutions were passed at its AGM, held in Jersey earlier today.

Interim Management Statement

Flying Brands Limited announces its Interim Management Statement as required by the FSA's Disclosure and Transparency rules. The financial commentary covers the first thirteen weeks of Flying Brands' current financial year, from 3 January to 3 April 2009. 

Trading

The Group has made a positive start to the current financial year and order intake for the ongoing business is £12.7mup 2.4% on a like for like basis against the same period last year, which is in line with the Board's expectations. We are focussing on tighter cost control and improving operational efficiency and the benefits of this are beginning to come through. However, we expect that the effects of these improvements will be more marked in the rest of the year. We have commenced a restructuring programme and we are targeting a reduction in salaried employee costs (which total approximately £3m) of more than 15%. Once again the full benefits of this programme will not be realised until the second half of the year. 

Flying Flowers' orders to 3 April 2009 were £3.1m compared with £3.3m in the equivalent period last year. However, we have improved margin contribution in this division and this will go a long way to making up for the decline in orders.

The Garden Division Spring 2009 season has started strongly and at 3 April the value of orders taken was £8.4m (2008: £7.8m). This improvement is attributable to a stronger performance from Gardening Direct and we continue to be encouraged by the response to our renewed customer recruitment activities in this area

Revenue for the Entertainment division was £1.3m, which is almost exactly level with the same period in 2008.

The closure of Greeting Direct continues as planned with revenue to 3 April 2009 of £0.8m (2008: £2.3M)

Financial position

There has been no material change in Flying Brands' financial position in the period. The Group's net cash position at 3 April 2009 was £1.0m (2008 net debt: £1.5m). The Group continues to pay down its debt on schedule and to comply with its banking covenants

For further information, please contact:

Flying Brands Limited 01245 228 300

Stephen Cook, Chief Executive

Graham Norton, Finance Director

Smithfield Consultants 020 7360 4900

John Kiely

Notes to editors

Jersey based Flying Brands Limited (LSE: FBDU) is a multi brand and multi channel home shopping specialist. Founded in 1981, it was admitted to the Official List of the London Stock Exchange in 1993. The Group operates the following divisions: 

Gifts (Flying Flowers, the UK's largest flowers by post brand,)

Garden (Gardening Direct, one of the UK's largest mail order bedding plants and gardening products operations; Garden Bird Supplies, a leading provider of food and accessories for birds and other wildlife)

Entertainment (Listen2, a leading mail order audio books, nostalgic music, DVD and video publisher and distributor; Benham, the first day cover stamps and coins collectables specialist)

More information can be found at: www.flyingbrands.com

Cautionary statement 

This report contains forward- looking statements. These have been made by the Directors in good faith based on the information available to them up to the time of their approval of this report. The Directors can give no assurance that these expectations will prove to have been correct. Due to inherent uncertainties, including both economic and business risk factors underlying such forward looking information, actual results may differ materially from those expressed or implied by these forward looking statements. The Directors undertake no obligation to update any forward looking statements whether as a result of new information, future events or otherwise.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMUUVWRKURSURR
Date   Source Headline
27th May 20257:00 amRNSChange of Name
22nd May 20252:23 pmRNSResult of AGM
2nd May 20257:29 amRNSApplication: FDA Breakthrough Therapy Designation
29th Apr 202510:49 amRNSNotice of AGM
25th Apr 20251:46 pmRNSPublication of Annual Report
11th Apr 20253:32 pmRNSPromising Preliminary Results of Phase 1 Study
18th Mar 202510:38 amRNSPlacing to raise £250,000
3rd Feb 20257:00 amRNSIB Expands Distribution with Blackford
22nd Jan 20257:00 amRNSOperations Update
10th Jan 20257:49 amRNSIB and Prism Secure First Installation
20th Nov 20247:00 amRNSImaging Biometrics Expands Distribution
19th Nov 202411:27 amRNSBoard Changes
5th Nov 20247:00 amRNSNew Patent Application and Trading Update
15th Oct 202410:28 amRNSHolding(s) in Company
14th Oct 202412:08 pmRNSHolding(s) in Company
14th Oct 202412:05 pmRNSPDMR dealing and TR1 announcement
11th Oct 202410:42 amRNSAcquisition of Interest by Braveheart
25th Jun 20249:59 amRNSIB Opens Expanded Access Program
14th Jun 20248:38 amRNSClinical Trial Updates
29th May 20243:08 pmRNSResult of AGM
23rd May 20247:00 amRNSMajor East Coast Health System Chooses IB Nimble
20th May 20247:10 amRNSSecond FDA Rare Pediatric Disease Designation
17th May 20247:00 amRNSIB Software Enhances Clinical Decision-Making
10th May 20248:15 amRNSRare Pediatric Disease Designation Granted to GaM
2nd May 202412:47 pmRNSIB Announces Expanded Access Program for GaM
29th Apr 20243:26 pmRNSPublication of Annual Report
5th Mar 20247:00 amRNSGrant of Options
1st Mar 20248:22 amRNSHolding(s) in Company
1st Mar 20248:20 amRNSHolding(s) in Company
26th Feb 20247:00 amRNSResult of Broker Option and Total Voting Rights
22nd Feb 20247:00 amRNSPlacing and Broker Option
9th Feb 202412:49 pmRNSFDA Application Update
2nd Feb 20248:39 amRNSIB awarded a $100,000 grant
22nd Jan 202410:05 amRNSHolding(s) in Company
15th Jan 20247:01 amRNSDirector Dealings and Conversion of CLNs
15th Jan 20247:00 amRNSHolding(s) in Company
10th Jan 20247:00 amRNSIB Launching an Expanded Access Program for GaM
19th Dec 20232:29 pmRNSImaging Biometrics granted FDA “Fast-Track”
5th Dec 202310:58 amRNSIQ-AI Announces Positive Interim Phase 1 Results
20th Nov 20231:42 pmRNSHolding(s) in Company
9th Nov 202311:38 amRNSDirector Dealing and Conversion of CLNs
8th Nov 202310:59 amRNSApplication for Pediatric Rare Disease Designation
6th Nov 20231:02 pmRNSHolding(s) in Company
18th Oct 20232:29 pmRNSUpdate Regarding Imaging Biometrics LLC
13th Oct 20238:55 amRNSIB Letter to Shareholders
9th Oct 20237:00 amRNSOrphan Drug Status to GaM and Total Voting Rights
3rd Oct 202311:30 amRNSHolding(s) in Company
19th Sep 20232:32 pmRNSIQ-AI shares cease trading on the OTCQB
8th Sep 20237:00 amRNSReduced Gadolinium Approach Validated'
18th Aug 202312:06 pmRNSUpdate on Collaboration Agreement with Mayo Clinic

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.